|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Biomimetic Therapeutics, Inc. (BMTI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
28,001,000 |
Market
Cap: |
N/A |
Last
Volume: |
250,541 |
Avg
Vol: |
119,317 |
52
Week Range: |
$9.49 - $9.49 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Novo A/s |
10% Owner |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,720,065) |
0 |
|
- |
|
Christensen Thorkil K. |
Director |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,507) |
0 |
|
- |
|
Friedlaender Gary E |
Director |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(38,549) |
0 |
|
- |
|
Friedlaender Gary E |
Director |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(64,957) |
0 |
|
- |
|
Friedlaender Gary E |
Director |
|
2013-03-01 |
4 |
D |
$9.07 |
$161,210 |
D/D |
(17,774) |
64,957 |
|
- |
|
Friedlaender Gary E |
Director |
|
2013-03-01 |
4 |
OE |
$2.63 |
$161,269 |
D/D |
38,736 |
70,754 |
|
- |
|
Pagano Russell P. |
VP, Reg. & Clinical Affairs |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(44,411) |
0 |
|
- |
|
Pagano Russell P. |
VP, Reg. & Clinical Affairs |
|
2013-03-01 |
4 |
D |
$9.07 |
$293,129 |
D/D |
(32,305) |
44,411 |
|
- |
|
Pagano Russell P. |
VP, Reg. & Clinical Affairs |
|
2013-03-01 |
4 |
OE |
$2.08 |
$145,600 |
D/D |
70,000 |
76,716 |
|
- |
|
Federico Charles |
Director |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(27,834) |
0 |
|
- |
|
Federico Charles |
Director |
|
2013-03-01 |
4 |
OE |
$2.63 |
$161,269 |
D/D |
38,736 |
27,834 |
|
- |
|
Federico Charles |
Director |
|
2013-03-01 |
4 |
D |
$9.07 |
$108,677 |
D/D |
(11,977) |
7,834 |
|
- |
|
Murphy James G |
Director |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(56,964) |
0 |
|
- |
|
Murphy James G |
Director |
|
2013-03-01 |
4 |
OE |
$2.63 |
$161,269 |
D/D |
38,736 |
56,964 |
|
- |
|
Watson Douglas G |
Director |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(96,021) |
0 |
|
- |
|
Watson Douglas G |
Director |
|
2013-03-01 |
4 |
OE |
$2.63 |
$161,269 |
D/D |
38,736 |
96,021 |
|
- |
|
Papasan Larry W |
Director |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(69,517) |
0 |
|
- |
|
Papasan Larry W |
Director |
|
2013-03-01 |
4 |
OE |
$2.63 |
$161,269 |
D/D |
38,736 |
69,517 |
|
- |
|
Bullock Lawrence E |
Chief Financial Officer |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(21,000) |
0 |
|
- |
|
Bullock Lawrence E |
Chief Financial Officer |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(89,151) |
0 |
|
- |
|
Lynch Samuel Eugene |
President and CEO |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,550) |
0 |
|
- |
|
Lynch Samuel Eugene |
President and CEO |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,392,923) |
0 |
|
- |
|
Lynch Samuel Eugene |
President and CEO |
|
2013-03-01 |
4 |
D |
$9.07 |
$704,336 |
D/D |
(77,623) |
1,392,923 |
|
- |
|
Lynch Samuel Eugene |
President and CEO |
|
2013-03-01 |
4 |
OE |
$2.08 |
$530,570 |
D/D |
221,000 |
1,470,546 |
|
- |
|
Ehrlich Christopher B |
Director |
|
2013-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,830,253) |
0 |
|
- |
|
230 Records found
|
|
Page 1 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|